Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-06 09:58:32

expired found date

-

created at

2024-06-04 06:33:06

updated at

2025-12-27 17:55:45

Domain name statistics

length

13

crc

21347

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

264439665

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

41712

mp size raw text

3786

mp inner links count

11

mp inner links status

20 (imported)

Open Graph

title

description

OBiO Technology (Shanghai) Corp., Ltd.

image

site name

author

updated

2025-12-15 07:57:09

raw text

OBiO Technology (Shanghai) Corp., Ltd. MENU 简体中文 ENG Home About Us Our Facilities SPIRO Site PINE Site OBiO Intelli-M Leadership Team Laboratory Sciences CDMO Solutions Process Development cGMP Manufacturing Viral Vector Oncolytic Virus Cell Therapy Products Plasmid & Nucleotides Quality & Regulatory Cold Chain Logistics Innovations Insights Press Releases Events Knowledge Center Investor Relations Contact Us Enable Gene Therapy For Better Lives Your Trustful Partner in Research and Manufacturing for Gene and Cell Therapy Make Gene Delivery Accessible Side-by-Side Navigation for Your Innovations Industrialize Your Product At OBiO End-to-End Offerings with Versatile Technical Platform For Global Customers OBiO has launched its state-of-the-art GMP facility Intelli-M in 2023 Providing client-centered and high-quality service as our commitment, we strive to become a world leading gene and cell therapy CRO/CDMO group. ...

Text analysis

redirect type

30 (window.location)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

4

text cyrillic

0

text characters

2943

text words

478

text unique words

262

text lines

127

text sentences

14

text paragraphs

3

text words per sentence

34

text matched phrases

2

text matched dictionaries

2

RSS

rss path

rss status

3 (priority 3 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap path

sitemap status

1 (priority 1 already searched, no matches found)

sitemap review version

1

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

-

sitemap process date

-

sitemap first import date

-

sitemap last import date

-